Back

Colchicine: do we need more evidence?

31 August 2025 (14:15 - 14:30)
Organised by: Logo
Congress Presentation Part of: Challenges in the implementation of therapies for long-term management in coronary artery disease Acute Coronary Syndromes ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jean-Claude Tardif

Montreal Heart Institute, Montreal (Canada)

4 More presentations in this session

Presentation thumbnail
The cardiovascular polypill: simplicity to tackle a complex problem
Professor F. Pinto (Lisbon, PT)
Slides Video
Presentation thumbnail
Stepwise approach to lipid-lowering therapies: which one, when, and for whom?
Doctor M. O'Donoghue (Boston, US)
Slides Video
Presentation thumbnail
Challenges in the implementation of therapies for long-term management in coronary artery disease - patient perspective
Mrs X. Pitsilli Kyriacou (Nicosia, CY)
Slides Video
Presentation thumbnail
Challenges in the implementation of therapies for long-term management in coronary artery disease - discussion
Video

Access the full session

Session thumbnail
Challenges in the implementation of therapies for long-term management in coronary artery disease
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Anti-inflammatory treatment for coronary artery disease
thumbnail
Congress Presentation
Safety and efficacy of colchicine in myocardial infarction: an updated systematic review and meta-analysis
thumbnail
Congress Presentation
Highlights from the study on colchicine for secondary prevention of stroke and other cardiovascular events

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources